-Reuters India’s efforts to clamp down on illegal mining have handed a $15 billion lifeline to global iron ore giants, and there could be more to come. Steps taken by central and state authorities to clean up the mining and export of iron ore have shut down output in two key producing states, slashing shipments and forcing steel mills to import a raw material the country has in abundance. Now the Shah Commission,...

-Outlook Don’t blame globalization for inequality – but rather policies hijacked by a few Economic globalization in the sense of expansion of foreign trade and investment is, of course, somewhat anaemic, reflecting the impact of global recession, although still vigorous in the sense of continuous international transmission of technology, information, ideas and social media. But in the world of politics and policymaking a cold wind is blowing, dimming earlier enthusiasm for global...

-The Wall Street Journal   While modern crop engineering faces endless red tape, more slipshod cross-breeding gets a free pass. India has enjoyed signal successes with genetic engineering in agriculture. But today the nation's relationship with this critical biotechnology is in total disarray, the victim of activists' scaremongering and government pandering. Delhi should know better. Following the adoption of the genetically improved varieties and intensive crop management practices of the Green Revolution, from 1960...

-One World South Asia South Asia’s households fall into poverty as the result of higher food prices as food prices increase. According to the latest Food Price Watch, global food prices increased 10% between June and July 2012 with staples such as wheat increasing 25% in the period. The crisis continued affecting food and nutrition security throughout South Asia. Bad weather, trade curbs, oil prices and bio-fuel diversions have all led to...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...